Literature DB >> 22251422

Insights on urinary NGAL obtained in a primary care setting.

Yuki Tomonaga1, Thomas Szucs, Patrice Ambühl, Stefan Nock, Martin Risch, Lorenz Risch.   

Abstract

BACKGROUND: A majority of patients developing acute kidney injury (AKI) receive medical care from their primary care physicians prior to the occurrence of conditions that predispose them to this complication.
METHODS: To characterize the uNGAL concentrations in primary care patients and to assess these concentrations with regard to different reference intervals, we conducted a multicenter, cross-sectional study with random selection of general practitioners (GP) from all GP offices in seven Swiss cantons. 1000 adults (566 females; mean age 57±17 years) were included.
RESULTS: The median absolute uNGAL was 21 ng/L. Elevated uNGAL (>100 ng/L) together with normal kidney test results (eGFR and albuminuria) were found in 6.5% of all patients. Females had a significantly higher uNGAL than did males. Among a multitude of different clinical and laboratory variables, only age, gender, liver function parameters, WBC and CRP were significantly associated with uNGAL levels in a multivariate analysis. When examining the proposed KDIGO classification of chronic kidney disease, the uNGAL levels at the given eGFR stages changed with increasing albuminuria stages and vice versa.
CONCLUSIONS: Age, gender, markers of inflammation and liver function, exert influences on uNGAL concentrations. A substantial proportion of patients exhibited normal kidney testing together with elevated uNGAL, potentially identifying patients with increased renal stress and at increased risk for the development of AKI. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22251422     DOI: 10.1016/j.cca.2012.01.001

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Is urinary neutrophil gelatinase-associated lipocalin able to predict acute kidney injury episodes in very low birth weight infants in clinical settings?

Authors:  Elvira Parravicini; Chiara Locatelli; John M Lorenz; Sheri L Nemerofsky; David A Bateman
Journal:  Pediatr Res       Date:  2016-07-13       Impact factor: 3.756

2.  Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.

Authors:  Daijun Xiang; Hongrui Zhang; Jie Bai; Junlong Ma; Mianyang Li; Jimin Gao; Chengbin Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 3.  Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications.

Authors:  E Singer; L Markó; N Paragas; J Barasch; D Dragun; D N Müller; K Budde; K M Schmidt-Ott
Journal:  Acta Physiol (Oxf)       Date:  2013-02-04       Impact factor: 6.311

4.  Storage Time and Urine Biomarker Levels in the ASSESS-AKI Study.

Authors:  Kathleen D Liu; Edward D Siew; W Brian Reeves; Jonathan Himmelfarb; Alan S Go; Chi-Yuan Hsu; Michael R Bennett; Prasad Devarajan; T Alp Ikizler; James S Kaufman; Paul L Kimmel; Vernon M Chinchilli; Chirag R Parikh
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

5.  Neutrophil gelatinase-associated lipocalin (NGAL) fails as an early predictor of contrast induced nephropathy in chronic kidney disease (ANTI-CI-AKI study).

Authors:  Werner Ribitsch; Gernot Schilcher; Franz Quehenberger; Stefan Pilz; Rupert H Portugaller; Martini Truschnig-Wilders; Robert Zweiker; Marianne Brodmann; Philipp Stiegler; Alexander R Rosenkranz; John W Pickering; Joerg H Horina
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

Review 6.  Radiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategies.

Authors:  Umar Sadat
Journal:  ISRN Radiol       Date:  2013-09-16

7.  Estimating the prevalence of elevated plasma neutrophil gelatinase associated lipocalin level in patients with acute coronary syndromes and its association with outcomes.

Authors:  Anandaroop Lahiri; Anoop George Alex; Paul V George
Journal:  Indian Heart J       Date:  2017-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.